LCM
CLB icon

Laurion Capital Management’s Core Laboratories CLB Stock Holding History

Laurion Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-46,633
Closed -$948K – 876
2020
Q2 		$948K Buy
+46,633
New +$836K 0.01% 475
2020
Q1 		– Sell
-14,241
Closed -$536K – 785
2019
Q4 		$536K Buy
+14,241
New +$640K ﹤0.01% 679

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Laurion Capital Management's CLB Position: Q3 2020 in Review

Laurion Capital Management sold out of Core Laboratories (CLB) in Q3 2020, closing a stake of 46,633 shares — an estimated $948K sold.

Laurion Capital Management first reported a position in CLB in Q4 2019 and held it in 2 quarters. The position peaked at $948K in Q2 2020. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

  • Laurion Capital Management reported no remaining Core Laboratories position as of Q3 2020 after selling out during the quarter.
  • Laurion Capital Management sold 46,633 Core Laboratories shares in Q3 2020, an estimated $948K.
  • Laurion Capital Management first reported a position in Core Laboratories in Q4 2019 and held it in 2 quarters.
  • Laurion Capital Management's Core Laboratories position peaked at $948K in Q2 2020.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.